Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 195

1.

Predicting Child-to-Adult Community Mental Health Service Continuation.

Cohen DA, Klodnick VV, Kramer MD, Strakowski SM, Baker J.

J Behav Health Serv Res. 2020 Feb 19. doi: 10.1007/s11414-020-09690-9. [Epub ahead of print]

PMID:
32076949
2.

The impact of having children on domain-specific life satisfaction: A quasi-experimental longitudinal investigation using the Socio-Economic Panel (SOEP) data.

Krämer MD, Rodgers JL.

J Pers Soc Psychol. 2019 Dec 19. doi: 10.1037/pspp0000279. [Epub ahead of print]

PMID:
31854998
3.

Quantifying Dispositional Fear as Threat Sensitivity: Development and Initial Validation of a Model-Based Scale Measure.

Kramer MD, Patrick CJ, Hettema JM, Moore AA, Sawyers CK, Yancey JR.

Assessment. 2019 Apr 4:1073191119837613. doi: 10.1177/1073191119837613. [Epub ahead of print]

PMID:
30947514
4.

Formulation of a measurement model for the boldness construct of psychopathy.

Patrick CJ, Kramer MD, Vaidyanathan U, Benning SD, Hicks BM, Lilienfeld SO.

Psychol Assess. 2019 May;31(5):643-659. doi: 10.1037/pas0000690. Epub 2019 Feb 7.

PMID:
30730192
5.

Long-term effects of pregnancy and childbirth on sleep satisfaction and duration of first-time and experienced mothers and fathers.

Richter D, Krämer MD, Tang NKY, Montgomery-Downs HE, Lemola S.

Sleep. 2019 Apr 1;42(4). pii: zsz015. doi: 10.1093/sleep/zsz015.

PMID:
30649536
6.

Modeling the Structure of Acute Sport-Related Concussion Symptoms: A Bifactor Approach.

Nelson LD, Kramer MD, Patrick CJ, McCrea MA.

J Int Neuropsychol Soc. 2018 Sep;24(8):793-804. doi: 10.1017/S1355617718000462. Epub 2018 Aug 6.

7.

Do screening and a randomized brief intervention at a Level 1 trauma center impact acute stress reactions to prevent later development of posttraumatic stress disorder?

Manser SS, Houck K, Kramer MD, Tabas IA, Brown CVR, Coopwood B.

J Trauma Acute Care Surg. 2018 Sep;85(3):466-475. doi: 10.1097/TA.0000000000001977.

PMID:
29787532
8.

Resilience and Posttraumatic Stress Disorder Symptoms in National Guard Soldiers Deployed to Iraq: A Prospective Study of Latent Class Trajectories and Their Predictors.

Polusny MA, Erbes CR, Kramer MD, Thuras P, DeGarmo D, Koffel E, Litz B, Arbisi PA.

J Trauma Stress. 2017 Aug;30(4):351-361. doi: 10.1002/jts.22199. Epub 2017 Aug 1.

PMID:
28763565
9.

Psychoneurometric assessment of dispositional liabilities for suicidal behavior: phenotypic and etiological associations.

Venables NC, Yancey JR, Kramer MD, Hicks BM, Krueger RF, Iacono WG, Joiner TE, Patrick CJ.

Psychol Med. 2018 Feb;48(3):463-472. doi: 10.1017/S0033291717001830. Epub 2017 Jul 17.

PMID:
28712365
10.

At-home partner sleep functioning over the course of military deployment.

Miller KE, Koffel E, Kramer MD, Erbes CR, Arbisi PA, Polusny MA.

J Fam Psychol. 2018 Feb;32(1):114-122. doi: 10.1037/fam0000262. Epub 2017 Jun 19.

PMID:
28627910
11.

Efficiently measuring dimensions of the externalizing spectrum model: Development of the Externalizing Spectrum Inventory-Computerized Adaptive Test (ESI-CAT).

Sunderland M, Slade T, Krueger RF, Markon KE, Patrick CJ, Kramer MD.

Psychol Assess. 2017 Jul;29(7):868-880. doi: 10.1037/pas0000384. Epub 2016 Nov 14.

PMID:
27841446
12.

Evidence of a prominent genetic basis for associations between psychoneurometric traits and common mental disorders.

Venables NC, Hicks BM, Yancey JR, Kramer MD, Nelson LD, Strickland CM, Krueger RF, Iacono WG, Patrick CJ.

Int J Psychophysiol. 2017 May;115:4-12. doi: 10.1016/j.ijpsycho.2016.09.011. Epub 2016 Sep 23.

13.

Social Causation Versus Social Erosion: Comparisons of Causal Models for Relations Between Support and PTSD Symptoms.

Shallcross SL, Arbisi PA, Polusny MA, Kramer MD, Erbes CR.

J Trauma Stress. 2016 Apr;29(2):167-75. doi: 10.1002/jts.22086.

PMID:
27077494
14.

Using reinforcement sensitivity to understand longitudinal links between PTSD and relationship adjustment.

Meis LA, Erbes CR, Kramer MD, Arbisi PA, Kehle-Forbes SM, DeGarmo DS, Shallcross SL, Polusny MA.

J Fam Psychol. 2017 Feb;31(1):71-81. doi: 10.1037/fam0000195. Epub 2016 Apr 14.

15.

The class-dimensional structure of PTSD before and after deployment to Iraq: Evidence from direct comparison of dimensional, categorical, and hybrid models.

Kramer MD, Arbisi PA, Thuras PD, Krueger RF, Erbes CR, Polusny MA.

J Anxiety Disord. 2016 Apr;39:1-9. doi: 10.1016/j.janxdis.2016.02.004. Epub 2016 Feb 11.

PMID:
26896605
16.

Personality traits and combat exposure as predictors of psychopathology over time.

Koffel E, Kramer MD, Arbisi PA, Erbes CR, Kaler M, Polusny MA.

Psychol Med. 2016 Jan;46(1):209-20. doi: 10.1017/S0033291715001798. Epub 2015 Sep 8.

17.

Optimizing efficiency of psychopathology assessment through quantitative modeling: development of a brief form of the Externalizing Spectrum Inventory.

Patrick CJ, Kramer MD, Krueger RF, Markon KE.

Psychol Assess. 2013 Dec;25(4):1332-48. doi: 10.1037/a0034864. Erratum in: Psychol Assess. 2014 Sep;26(3):805.

18.

A construct-network approach to bridging diagnostic and physiological domains: application to assessment of externalizing psychopathology.

Patrick CJ, Venables NC, Yancey JR, Hicks BM, Nelson LD, Kramer MD.

J Abnorm Psychol. 2013 Aug;122(3):902-16. doi: 10.1037/a0032807. Review.

19.

Dimethyl sulfoxide (DMSO) exacerbates cisplatin-induced sensory hair cell death in zebrafish (Danio rerio).

Uribe PM, Mueller MA, Gleichman JS, Kramer MD, Wang Q, Sibrian-Vazquez M, Strongin RM, Steyger PS, Cotanche DA, Matsui JI.

PLoS One. 2013;8(2):e55359. doi: 10.1371/journal.pone.0055359. Epub 2013 Feb 1.

20.

Development and preliminary validation of a simplified-wording form of the multidimensional personality questionnaire.

Patrick CJ, Kramer MD, Tellegen A, Verona E, Kaemmer BA.

Assessment. 2013 Aug;20(4):405-18. doi: 10.1177/1073191112467051. Epub 2012 Nov 23.

PMID:
23180862
21.

Delineating physiologic defensive reactivity in the domain of self-report: phenotypic and etiologic structure of dispositional fear.

Kramer MD, Patrick CJ, Krueger RF, Gasperi M.

Psychol Med. 2012 Jun;42(6):1305-20. doi: 10.1017/S0033291711002194. Epub 2011 Oct 19.

PMID:
22008475
22.

Linking antisocial behavior, substance use, and personality: an integrative quantitative model of the adult externalizing spectrum.

Krueger RF, Markon KE, Patrick CJ, Benning SD, Kramer MD.

J Abnorm Psychol. 2007 Nov;116(4):645-66.

23.
24.

Gender differences and developmental change in externalizing disorders from late adolescence to early adulthood: A longitudinal twin study.

Hicks BM, Blonigen DM, Kramer MD, Krueger RF, Patrick CJ, Iacono WG, McGue M.

J Abnorm Psychol. 2007 Aug;116(3):433-47.

25.

Synaptic glutamate release by ventromedial hypothalamic neurons is part of the neurocircuitry that prevents hypoglycemia.

Tong Q, Ye C, McCrimmon RJ, Dhillon H, Choi B, Kramer MD, Yu J, Yang Z, Christiansen LM, Lee CE, Choi CS, Zigman JM, Shulman GI, Sherwin RS, Elmquist JK, Lowell BB.

Cell Metab. 2007 May;5(5):383-93.

26.

Sonorheometry: a noncontact method for the dynamic assessment of thrombosis.

Viola F, Kramer MD, Lawrence MB, Oberhauser JP, Walker WF.

Ann Biomed Eng. 2004 May;32(5):696-705.

PMID:
15171624
27.

Classroom injuries in Utah public schools.

Kramer MD, Lightfoot AC, Knight S, Cazier CF, Olson LM.

Acad Emerg Med. 2003 Sep;10(9):978-84.

28.

Human VAT-1: a calcium-regulated activation marker of human epithelial cells.

Koch J, Foekens J, Timmermans M, Fink W, Wirzbach A, Kramer MD, Schaefer BM.

Arch Dermatol Res. 2003 Sep;295(5):203-10. Epub 2003 Jul 30.

PMID:
12898150
29.

uPA-silica-Particles (SP-uPA): a novel analytical system to investigate uPA-uPAR interaction and to test synthetic uPAR antagonists as potential cancer therapeutics.

Guthaus E, Bürgle M, Schmiedeberg N, Hocke S, Eickler A, Kramer MD, Sweep CG, Magdolen V, Kessler H, Schmitt M.

Biol Chem. 2002 Jan;383(1):207-16.

PMID:
11930939
30.

Molecular and functional characterization of the four-transmembrane molecule l6 in epidermal keratinocytes.

Storim J, Friedl P, Schaefer BM, Bechtel M, Wallich R, Kramer MD, Reinartz J.

Exp Cell Res. 2001 Jul 15;267(2):233-42.

PMID:
11426942
31.

Expression of the helix-loop-helix protein ID1 in keratinocytes is upregulated by loss of cell-matrix contact.

Schaefer BM, Koch J, Wirzbach A, Kramer MD.

Exp Cell Res. 2001 Jun 10;266(2):250-9.

PMID:
11399053
32.

Molecular and biochemical characterization of a cytokinin oxidase from maize.

Bilyeu KD, Cole JL, Laskey JG, Riekhof WR, Esparza TJ, Kramer MD, Morris RO.

Plant Physiol. 2001 Jan;125(1):378-86.

33.

New ELISA for quantitation of human urokinase receptor (CD87) in cancer.

Kotzsch M, Luther T, Harbeck N, Ockert D, Lutz V, Noack F, Grossmann D, Albrecht S, Kramer MD, Lossnitzer A, Grosser M, Schmitt M, Magdolen V.

Int J Oncol. 2000 Oct;17(4):827-34.

PMID:
10995898
34.

The membrane-associated protein pKe#192/MAP17 in human keratinocytes.

Jaeger C, Schaefer BM, Wallich R, Kramer MD.

J Invest Dermatol. 2000 Sep;115(3):375-80.

35.

Epitope mapping of monoclonal antibodies directed to PAI-1 using PAI-1/PAI-2 chimera and PAI-1-derived synthetic peptides.

Muehlenweg B, Guthaus E, de Prada NA, Schmitt M, Schmiedeberg N, Kotzsch M, Creutzburg S, Kramer MD, Kessler H, Wilhelm OG, Magdolen V.

Thromb Res. 2000 Apr 1;98(1):73-81.

PMID:
10706935
36.

Immunohistochemical and molecular characterization of cultured keratinocytes after dispase-mediated detachment from the growth substratum.

Schaefer BM, Wallich R, Schmolke K, Fink W, Bechtel M, Reinartz J, Kramer MD.

Exp Dermatol. 2000 Feb;9(1):58-64.

PMID:
10688376
37.

The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients.

Foekens JA, Peters HA, Look MP, Portengen H, Schmitt M, Kramer MD, Brünner N, Jänicke F, Meijer-van Gelder ME, Henzen-Logmans SC, van Putten WL, Klijn JG.

Cancer Res. 2000 Feb 1;60(3):636-43.

38.
39.

External quality assessment of trans-European multicentre antigen determinations (enzyme-linked immunosorbent assay) of urokinase-type plasminogen activator (uPA) and its type 1 inhibitor (PAI-1) in human breast cancer tissue extracts.

Sweep CG, Geurts-Moespot J, Grebenschikov N, de Witte JH, Heuvel JJ, Schmitt M, Duffy MJ, Jänicke F, Kramer MD, Foekens JA, Brünner N, Brugal G, Pedersen AN, Benraad TJ.

Br J Cancer. 1998 Dec;78(11):1434-41.

40.

Therapy with a purified plasminogen concentrate in an infant with ligneous conjunctivitis and homozygous plasminogen deficiency.

Schott D, Dempfle CE, Beck P, Liermann A, Mohr-Pennert A, Goldner M, Mehlem P, Azuma H, Schuster V, Mingers AM, Schwarz HP, Kramer MD.

N Engl J Med. 1998 Dec 3;339(23):1679-86. No abstract available.

41.

Semi-quantitation of urokinase plasminogen activator and its receptor in breast carcinomas by immunocytochemistry.

Kennedy S, Duffy MJ, Duggan C, Barnes C, Rafferty R, Kramer MD.

Br J Cancer. 1998 May;77(10):1638-41.

42.

Autoantibodies to polymorphonuclear neutrophil elastase do not inhibit but enhance elastase activity.

Morcos M, Zimmermann F, Radsak M, Wörner I, Kramer MD, Roland J, Hänsch GM, Andrassy K.

Am J Kidney Dis. 1998 Jun;31(6):978-85.

PMID:
9631842
43.

Epitopes of components of the plasminogen activation system are re-exposed in formalin-fixed paraffin sections by different retrieval techniques.

Ferrier CM, van Geloof WL, de Witte HH, Kramer MD, Ruiter DJ, van Muijen GN.

J Histochem Cytochem. 1998 Apr;46(4):469-76.

PMID:
9524192
44.

Plasminogen activator inhibitor type 2 is expressed in keratinocytes during re-epithelialization of epidermal defects.

Bechtel MJ, Wysocki NS, Heidtmann A, Stark HJ, Fusenig N, Kramer MD, Schaefer BM.

Br J Dermatol. 1998 Jan;138(1):22-8.

PMID:
9536219
45.
46.

Thoracoscopy in acquired immunodeficiency syndrome.

Flum DR, Steinberg SD, Bernik TR, Bonfils-Roberts E, Kramer MD, Adams PX, Wallack MK.

J Thorac Cardiovasc Surg. 1997 Sep;114(3):361-6.

47.

Prognostic relevance of urokinase plasminogen activator detection in micrometastatic cells in the bone marrow of patients with primary breast cancer.

Solomayer EF, Diel IJ, Wallwiener D, Bode S, Meyberg G, Sillem M, Gollan C, Kramer MD, Krainick U, Bastert G.

Br J Cancer. 1997;76(6):812-8.

48.

Plasminogen activator inhibitor type 2 in breast cancer.

Duggan C, Kennedy S, Kramer MD, Barnes C, Elvin P, McDermott E, O'Higgins N, Duffy MJ.

Br J Cancer. 1997;76(5):622-7.

49.

Protective immunization with plasmid DNA containing the outer surface lipoprotein A gene of Borrelia burgdorferi is independent of an eukaryotic promoter.

Simon MM, Gern L, Hauser P, Zhong W, Nielsen PJ, Kramer MD, Brenner C, Wallich R.

Eur J Immunol. 1996 Dec;26(12):2831-40.

PMID:
8977275
50.

Plasminogen activator system in pemphigus vulgaris.

Schaefer BM, Jaeger CJ, Kramer MD.

Br J Dermatol. 1996 Nov;135(5):726-32.

PMID:
8977672

Supplemental Content

Loading ...
Support Center